Bubble Robotics | $5,000,000 | (Apr 23, 2026)
C-Infinity | $16,000,000 | (Apr 23, 2026)
Mosaic(US) | $18,000,000 | (Apr 23, 2026)
Certified by Founder
Lodge
Altesa BioSciences, Inc.
start up
United States
- Atlanta, GA
- 20/02/2026
- Series B
- $75,000,000
Altesa is an innovative, clinical-stage pharmaceutical company dedicated to preventing and treating the leading cause of COPD and asthma exacerbations -- namely viral respiratory infections -- starting with rhinovirus, the most common respiratory virus on the planet.
Our goal is to disrupt the COPD treatment paradigm by targeting the upstream cause of acute respiratory exacerbations -- not accept the status quo of managing the long term downstream consequences like chronic inflammation, hospitalizations and even death.
- Industry Biotechnology Research
- Website https://www.altesabio.com/
- LinkedIn https://www.linkedin.com/company/altesa-biosciences/
Omeza | $8,500,000 | (Apr 23, 2026)
Calibre | $3,300,000 | (Apr 23, 2026)
Nox Mobility | $2,341,030 | (Apr 23, 2026)
BuildForever | $9,500,000 | (Apr 23, 2026)
10x Science (YC W26) | $4,800,000 | (Apr 23, 2026)
Schematic | $6,500,000 | (Apr 23, 2026)
Crewline | $7,100,000 | (Apr 23, 2026)
Monk | $25,000,000 | (Apr 22, 2026)
NeoCognition | $40,000,000 | (Apr 22, 2026)